Paris-based health tech startup Nabla has successfully closed a Series B funding round, securing a substantial $24 million, with Cathay Innovation leading the investment, and participation from ZEBOX Ventures, the corporate VC fund of CMA CGM. This financial boost comes hot on the heels of Nabla’s significant partnership with Permanente Medical Group, a division of the prominent U.S. healthcare entity, Kaiser Permanente.
Sources reveal that Nabla has now reached an impressive valuation of $180 million post the Series B funding round, and there’s potential for additional investments from U.S. backers. Nabla has been diligently working on an AI copilot designed to assist doctors and medical professionals. Think of it as a silent work partner, residing in the corner of the room, diligently taking notes and crafting medical reports during consultations.
Founded by Alexandre Lebrun, Delphine Groll, and Martin Raison, Nabla’s CEO, Alexandre Lebrun, was previously the CEO of Wit.ai, an AI assistant startup acquired by Facebook. The startup’s innovative solution uses speech-to-text technology to transcribe medical consultations, whether conducted in person or via telehealth. A recent live demo showcased Nabla’s efficiency in generating accurate transcripts and comprehensive medical reports, even in a crowded room, proving its effectiveness.
Nabla’s copilot, aptly named Nabla Copilot, aims to complement rather than replace human expertise. Physicians retain the final say, with the ability to edit reports before filing them in their electronic health record (EHR) system. The startup envisions progressing through different levels of automation, akin to the evolution of autonomous vehicles, gradually enhancing clinical assurance support and clinical decision support with FDA approval.
While Nabla is based in France, a substantial portion of its user base is in the U.S., particularly following its rollout across Permanente Medical Group. Nabla, actively used daily by thousands of doctors, is not merely a work in progress but a practical and impactful solution in the healthcare sector.
